Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Fanconi Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stanford University, Stanford, California, United States
Contact: Study coordinator (Rajni Agarwal, MD) · scgt_clinical_trials_office@lists.stanford.edu · 650-725-9250

Study leads

Rajni Agarwal, MD
Principal Investigator
Stanford University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Fanconi Anemia · Severe Aplastic Anemia · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Primary Immune Deficiency Disorder · Immune Deficiency Disease · Bone Marrow Failure

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Fanconi Anemia · Severe Marrow Failure · Myelodysplastic Syndrome (MDS)

Abroad (travel likely)RecruitingPHASE2

New York, United States · Cincinnati, United States

Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Fanconi Anemia · Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hanover, Germany · Barcelona, Spain